US35085K1097 - ADR
4D Pharma PLC
NASDAQ:LBPS (6/24/2022, 7:00:03 PM)
1.65
+0.04 (+2.48%)
4D Pharma Plc is a pharmaceutical company, which engages in the development of live bio therapeutics. The firm is focused on developing Live Biotherapeutic Products (LBPs), a class of drugs derived from the human gut microbiome. The firm's LBPs are biologics based on live organisms, namely single strains of bacteria. The company has developed MicroRx, its LBP discovery platform. MicroRx interrogates its library of bacterial isolates for therapeutic functionality and characterizes the bacterial isolates using a range of complementary tools and technologies. Its microbiome profiling platform, MicroDx, analyses the microbiome to aid the diagnosis and treatment of patients with its Live Biotherapeutics. Its MicroRx platform has generated a pipeline of development programs in therapeutic areas, including immuno-oncology, gastrointestinal (GI), respiratory, autoimmune and central nervous system (CNS) diseases. Its MicroRx enables the discovery of MRx-4DP0004, which is engaged in an ongoing Phase I/II with partly controlled asthma.
4D Pharma PLC
9 Bond Court
LEEDS LS1 2JZ
P: 441138950130.0
CEO: Duncan Peyton
Employees: 95
Website: https://www.4dpharmaplc.com/
Good morning! It's time to start off another busy day of trading with a dive into the biggest pre-market stock movers for Tuesday!
Here you can normally see the latest stock twits on LBPS, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: